Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
56 hedge funds and large institutions have $59.1M invested in Windtree Therapeutics Inc in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 13 closing their positions.
109% more call options, than puts
Call options by funds: $427K | Put options by funds: $204K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 62 → 56 (-6)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
37% less capital invested
Capital invested by funds: $93.8M → $59.1M (-$34.7M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$940K |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$357K |
| 3 |
Morgan Stanley
New York
|
+$345K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$160K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$893K |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$615K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$256K |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$189K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$144K |
WINT Hedge Fund Activity: Q4 2014 in Review
56 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2014, worth a combined $59.1M — down 37% from $93.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of WINT and 8 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was Millennium Management, adding an estimated $940K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $893K sold.
- 56 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2014, down from 62 in Q3 2014.
- Funds reported $59.1M of Windtree Therapeutics Inc stock for Q4 2014, down 37% quarter-over-quarter.
- 8 funds opened new Windtree Therapeutics Inc positions in Q4 2014 and 13 closed out, a net change of -5 holders.
- The largest Windtree Therapeutics Inc buyer in Q4 2014 was Millennium Management, an estimated $940K added.
- The largest Windtree Therapeutics Inc seller in Q4 2014 was Sphera Funds Management, an estimated $893K sold.
Based on aggregated 13F filings for Q4 2014.